FRANKLIN LAKES, N.J. , Aug. 17, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Gary Sorsher has been named...
Becton, Dickinson and Company has underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.
Enrollment completed in the first large-scale randomized study evaluating Phasix™ Mesh for incisional hernia prevention, a significant unmet need following abdominal surgery
Becton Dickinson: Fiscal Q3 Earnings Snapshot
FRANKLIN LAKES, N.J. , Aug. 6, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its fiscal 2026 third...
Barchart Research What to Expect from BDX Earnings BDX Generated August 5, 2026 Current Price $170.66 EPS Estimate $$3.14 Consensus Rating Moderate Buy Average Move 5.41% BD's Three Consecutive Quarters...
Collaboration pairs leadership in pharmaceuticals and advanced drug delivery technology to support a consistent, reliable treatment experience for metabolic disease patients.
FRANKLIN LAKES, N.J. , July 28, 2026 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has...
FRANKLIN LAKES, N.J. , July 22, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Dr. Michael (Mike) Garrison...
Becton, Dickinson and Company will release its third-quarter earnings next month, and analysts anticipate a double-digit profit dip.